gp100 Peptide Vaccine and Interleukin-2 in Patients with Advanced Melanoma
gp100 Peptide Vaccine and Interleukin-2 in Patients with Advanced Melanoma is a paper indexed in ScholarIQ from OpenAlex.
How many citations does gp100 Peptide Vaccine and Interleukin-2 in Patients with Advanced Melanoma have?
gp100 Peptide Vaccine and Interleukin-2 in Patients with Advanced Melanoma has 895 citations in the OpenAlex counts ScholarIQ stores.
When was gp100 Peptide Vaccine and Interleukin-2 in Patients with Advanced Melanoma published?
gp100 Peptide Vaccine and Interleukin-2 in Patients with Advanced Melanoma has 2011 year in the ScholarIQ index.
What is the open-access status of gp100 Peptide Vaccine and Interleukin-2 in Patients with Advanced Melanoma?
gp100 Peptide Vaccine and Interleukin-2 in Patients with Advanced Melanoma has closed oa status in the ScholarIQ index.
What is the DOI of gp100 Peptide Vaccine and Interleukin-2 in Patients with Advanced Melanoma?
The DOI for gp100 Peptide Vaccine and Interleukin-2 in Patients with Advanced Melanoma is on the source record.
What is the PMID of gp100 Peptide Vaccine and Interleukin-2 in Patients with Advanced Melanoma?
The PMID for gp100 Peptide Vaccine and Interleukin-2 in Patients with Advanced Melanoma is on the source record.
What is the OpenAlex record for gp100 Peptide Vaccine and Interleukin-2 in Patients with Advanced Melanoma?
The OpenAlex for gp100 Peptide Vaccine and Interleukin-2 in Patients with Advanced Melanoma is on the source record.